ISSN 2410-776X (Online),
ISSN 2410-7751 (Print)
Biotechnologia Acta, V. 8, No 1, 2015;
https://doi.org/10.15407/biotech8.01.039
P. 39-48, Bibliography 25, English
Universal Decimal classification: 54.057+547.311+576.5+577+615.9+616-006
1 Institute of Cell Biology of the National Academy of Sciences of Ukraine, Lviv
2 Danylo Halytsky Lviv National Medical University, Ukraine
3 Lviv National Polytechnic University, Ukraine
A nanoscale polymeric carrier was used for delivery of novel anticancer compounds – 4-tiazolidinone derivatives – to tumor cells of different lines. It was found that such way of delivery of the above mentioned compounds to target cells significantly (approximately 10 times) decreased acting cytotoxic dose of some of these compounds with preservation of similar level of their antineoplastic effect in vitro towards various mammalian tumor cells. The microscopic investigation of these cells demonstrated that under the action of some immobilized 4-tiazolidonone derivatives, there was an increase (up to 40%) of the part of apoptotic cells, as well as an appearance of 10% of cells with morphologically changed nucleus, and up to 35% of cells with an increased intensity of red fluorescence of acridine orange in the lysosomes, compared with such indicators observed under the action of free form of those compounds. Thus, the applied nanoscale carrier is a perspective polymer system for delivery of anticancer drugs to target cells.
Кey words: 4-tiazolidinone derivatives, nanoscale polymer carrier.
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2015
References
- Caruthers S. D., Wickline S. A., Lanza G. M. Nanotechnological applications in medicine. Curr. Opin. Biotechnol. 2007, V. 18, P. 26–30.
http://dx.doi.org/10.1016/j.copbio.2007.01.006 - Clavinas H., Crajcsi P., Cserepes J., Sarcadi B. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr. Drug Deliv. 2004, V. 1, P. 27–42.
http://dx.doi.org/10.2174/1567201043480036 - Wang T., D'Souza G. G., Bedi D., Fagbohun O. A., Potturi L. P., Papahadjopoulos-Sternberg B., Petrenko V., A., Torchilin V.P. Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein. Nanomedicine (Lond). 2010, 5 (4), 563–574.
http://dx.doi.org/10.2217/nnm.10.30 - Zhang F., Zhu L., Liu G., Hida N., Lu G. Eden H. S., Niu G., Chen X. Multimodality Imaging of Tumor Response to Doxil. Theranostics. 2011, V. 1, P. 302–309.
http://dx.doi.org/10.7150/thno/v01p0302 - Senkiv Y., Riabtseva A., Heffeter P., Boiko N., Kowol C. R., Jungwith U., Shiyakhina Y., Garasevych S. G., Mitina N., Berger W., Zaichenko A., Stoika R. Enhanced anticancer activity and circumvention of resistance mechanisms by novel polymeric/phospholipidic nanocarriers of doxorubicin. J. Biomed. Nanotechnol. 2014, 10 (7), 1369–1381.
http://dx.doi.org/10.1166/jbn.2014.1864 - Boiko N. M., Senkiv Yu. V., Shlyakhtina Ye. A., Kluchivska O. Yu., Moskvin M. M., Zaichenko. O. S., Stoika R. S. Action of doxorubicin delivered to tumor cells in vitro and in vivo by novel functional oligoelectrolytic carrier. Biotechnologia Acta. 2013, 6 (3), 53–62.
http://dx.doi.org/10.15407/biotech6.03.053 - Senkiv Yu. V., Heffeter P., Riabtseva A. O., Boiko N. M., Zaichenko. O. S., Berger W., Stoika R. S. . Action of free and polymer carrier encapsulated doxorubicin towards HCT 116 cells of human colorectal carcinoma. Ukr. Biochem. J. 2013, 85 (2), 33–44.
- Lesyk R., Zimenkovsky B. 4-Thiazolidones: centenarian history, current status and perspectives for modern organic and medicinal chemistry. Curr. Org. Chem. 2004, V. 8, P. 1547–1577.
http://dx.doi.org/10.2174/1385272043369773 - Lesyk R. B., Zimenkovsky B. S., Kaminskyy D. V., Kryshchyshyn A. P., Havryluk D., Yu., Atamanyuk D. V. Subtelna I. Yu., Khyluk D. V. Thiazolidinone motif in anticancer drug discovery. Experience of DH LNMU medicinal chemistry scientific group. Biopolymers and Cell. 2011, V. 27, P. 107–117.
http://dx.doi.org/10.7124/bc.000089 - Havrylyuk D., Zimenkovsky B., Vasylenko O. Day C. W., Smee D. F., Grellier P., Lesyk R. Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones. Eur. J. Med. Chem. 2013, V. 66, P. 228–237.
http://dx.doi.org/10.1016/j.ejmech.2013.05.044 - Havrylyuk D., Zimenkovsky B., Vasylenko O., Grellier P., Lesyk R. Synthesis of new 4 thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity. J. Med. Chem. 2012, V. 55, P. 8630?8641. (In Ukrainian).
http://dx.doi.org/10.1021/jm300789g - Havrylyuk D., Zimenkovsky B., Vasylenko O., Lesyk R. Synthesis, anticancer and antiviral activity of new 2-pyrazoline substituted 4-thiazolidinones. J. Heterocyclic Chem. 2013, V. 50, P. E55–E62.
http://dx.doi.org/10.1002/jhet.1056 - Havrylyuk D., Zimenkovsky B., Vasylenko O., Zaprutko L., Grella A., Lesyk R. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Eur. J. Med. Chem. 2009, V. 44, P. 1396–1404.
http://dx.doi.org/10.1016/j.ejmech.2008.09.032 - Patent UA u201114202, №69857. 3-{2-[5-(3,5-diaril)-4,5-dihydropirazol-1-il]-4-oxo-4H-thiazol-5-iliden}-1,3-dyhidroindol-2-ons, that possess anticancer activity. Havrylyuk D. Ya., Zimenkovsky B. S., Lesyk R. B., Roman O. M. – Pub. 10. 05. 2012, Bul. N 19. (In Ukrainian).
- Vine K., Locke J., Ranson M., Benkendorff K., Pyne S. Bremner J. B. In vitro cytotoxicity evaluation of some substituted isatin derivatives. Bioorg. Med. Chem. 2007, 15 (2), 931–938.
http://dx.doi.org/10.1016/j.bmc.2006.10.035 - Kobylinska L., Havrylyuk D., Patereha I., Kotsyumbas I., Lesyk R., Stoika R. Study of acute toxicity and cumulative properties in rats of novel synthetic 4-tiazolidone derivatives with potential antineoplastic activity. Sovremennie problemi toxivologyy, pitamia I chimicheskoy bezopasnosti. 2013, 4 (63), 38–43. (In Ukrainian).
- Kobylinska L. I., Havrylyuk D.Ya., Ryabtseva A.O., Mitina N.E., Zaichenko O.S., Zimenkovsky B.S., Stoika R.S. Study of rat blood serum biochemical indicators of cardiotoxic action of novel 4-thiazolidone derivatives and doxorubicin in complexes with polyethylenglycol-containing polymeric carrier. Ukr. Biochem. J. 2014, 86 (6), 84–95. (In Ukrainian).
- Heffeter P., Riabtseva A., Senkiv Y., Kovol C. R., K?rner W., Jungwith U., Mitina N. E., Keppler B. K., Konstantonova T., Yanchuk I., Stoika R. S., Zaichenko O. S., Berger W. Nanoformulation Improves Activity of the (pre)Clinical Anticancer Ruthenium Complex KP1019. J. Biomed. Nanotechnol. 2014, 10 (5), 877–884.
http://dx.doi.org/10.1166/jbn.2014.1763 - Toroptseva A. M., Belogorodskaya K. V., Bondarenko V. M. Laboratory Manual on Chemistry and Technology of High molecular Compounds. L.: Chemistry. 1972, 416 p. (In Russian).
- Rabek Ya. Experimental Methods in Polymer Chemistry. Part 1, 2. – Moskow: Mir. 1983, 862 p. (In Russian).
- Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M. A., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry. 1992, 13 (8), 795–808.
http://dx.doi.org/10.1002/cyto.990130802 - Sopin Ye. F., Vynohradova R. P. Basis of biochemical methods of investigation. Kyiv: Vyscha shkola. 1975, 244 p. (In Ukrainian).
- Horbay R. O., Manko B. O., Manko V. V., Lootsik., Stoika R. S. Respiration characteristics of mitochondria in parental and giant transformed cells of murine Nemeth-Kellner lymphoma. Cell Biol. Int. 2011, V. 35, P. 1–7.
- Horbay R., Stoika R. Giant cell formation: way to cell death or cell survival? Centr. Eur. J. Biol. 2011, 6 (5), 675–684.
http://dx.doi.org/10.2478/s11535-011-0058-0 - Horbay R. O., Kashchak N. I., Stoika R. S. A comparison of paclitaxel and vinblastine induced giant cell formation in murine NK/Ly lymphoma. Stud. Biol. 2011, 5 (1), 69–76.